Two new drug treatments for variant CJD, the human version of mad cow
disease, will be tested in Britain. A team led by Carsten Korth and Stanley
Prusiner at the University of California, San Francisco, has found that both
drugs—already used to treat malaria and schizophrenia—halt the
progress of the disease in cell culture. A 20-year-old British woman with vCJD
is reported to have shown marked improvement following treatment, but a second
patient is said to be no better. The Department of Health says the drugs could
be tested on seven British vCJD patients as soon as trials…
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
2
Collapse of key ocean current may release billions of tonnes of carbon
3
The biggest threat to Chernobyl is no longer radiation
4
How autoimmune conditions can unexpectedly drive mental illness
5
The man who crawls into the perilous heart of the Chernobyl reactor
6
A key solution to climate change isn't happening – and that's good
7
Electric vehicle owners could earn thousands by supporting power grid
8
My life as a meteorologist in Chernobyl under Russian occupation
9
Neanderthal infants were enormous compared with modern humans
10
Plug-in solar is coming – how dangerous is it and is it worth it?
